COMPANY

Lena Biosciences, Inc.

Lena Biosciences is a life sciences company providing drug discovery platforms with human-relevant data for the development of safe and effective medicines. From company website Source · Oct 12, 2026

Keywords: drug discovery

Profile checked Oct 10, 2026

11NIH grants

Timeline

Aug 7, 2025 Grant Government grant — SBIR: $1.06M (annual award, as published), announced Aug 7, 2025. Agency: NIH/NIEHS. Source: government award database. source ↗

Funding

Last 2 years.

Aug 7, 2025 Government grant — SBIR: $1.06M (annual award, as published), announced Aug 7, 2025. Agency: NIH/NIEHS. Source: government award database. source ↗

NIH awards 11

Annual award amounts. Total $5.5M.

Aug 22, 2024 NIH award 1R44ES036492-01A1 FY2024: $900,804 awarded for that fiscal year; activity R44 (SBIR); PI VUKASINOVIC, JELENA; recipient as written: LENA BIOSCIENCES, INC., ATLANTA, GA. An integrated MPS platform with "virt source ↗
May 6, 2024 NIH award 5R44ES032355-03 FY2024: $922,650 awarded for that fiscal year; activity R44 (SBIR); PI VUKASINOVIC, JELENA; recipient as written: LENA BIOSCIENCES, INC., ATLANTA, GA. Perfused organ panel as an animal surro source ↗
May 5, 2023 NIH award 2R44ES032355-02A1 FY2023: $881,176 awarded for that fiscal year; activity R44 (SBIR); PI VUKASINOVIC, JELENA; recipient as written: LENA BIOSCIENCES, INC., ATLANTA, GA. Perfused organ panel as an animal sur source ↗
Apr 22, 2023 NIH award 5R43TR004290-02 FY2023: $78,873 awarded for that fiscal year; activity R43 (SBIR); PI VUKASINOVIC, JELENA; recipient as written: LENA BIOSCIENCES, INC., ATLANTA, GA. A microphysiological system with a synth source ↗
May 20, 2022 NIH award 1R43TR004290-01 FY2022: $221,075 awarded for that fiscal year; activity R43 (SBIR); PI VUKASINOVIC, JELENA; recipient as written: LENA BIOSCIENCES, INC., ATLANTA, GA. A microphysiological system with a synt source ↗
Jul 30, 2020 NIH award 1R43ES032355-01 FY2020: $252,124 awarded for that fiscal year; activity R43 (SBIR); PI VUKASINOVIC, JELENA; recipient as written: LENA BIOSCIENCES, INC., ATLANTA, GA. Perfused organ panel as an animal surro source ↗
Jul 10, 2019 NIH award 5R44TR001286-03 FY2019: $721,610 awarded for that fiscal year; activity R44 (SBIR); PI VUKASINOVIC, JELENA; recipient as written: LENA BIOSCIENCES, INC., ATLANTA, GA. Tools for drug efficacy studies in perf source ↗
Jun 22, 2018 NIH award 2R44TR001286-02 FY2018: $724,224 awarded for that fiscal year; activity R44 (SBIR); PI VUKASINOVIC, JELENA; recipient as written: LENA BIOSCIENCES, INC., ATLANTA, GA. Tools for drug efficacy studies in perf source ↗
Apr 26, 2016 NIH award 1R43TR001286-01A1 FY2016: $325,000 awarded for that fiscal year; activity R43 (SBIR); PI VUKASINOVIC, JELENA; recipient as written: LENA BIOSCIENCES, INC., ATLANTA, GA. Tools for drug efficacy studies in pe source ↗
Jul 21, 2010 NIH award 5R43NS065543-02 FY2010: $244,894 awarded for that fiscal year; activity R43 (SBIR); PI VUKASINOVIC, JELENA; recipient as written: LENA BIOSCIENCES, INC., ATLANTA, GA. Diagnostic Microperfusion Platfom for F source ↗
Sep 15, 2009 NIH award 1R43NS065543-01A1 FY2009: $194,959 awarded for that fiscal year; activity R43 (SBIR); PI VUKASINOVIC, JELENA; recipient as written: LENA BIOSCIENCES, INC., ATLANTA, GA. Diagnostic Microperfusion Platfom for source ↗